Nanoform Commenced Relative Bioavailability Study of Nanotec

/PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance enhancing company, today announced it had completed the First Subject First Visit...

Related Keywords

Finland , Stockholm , Sweden , Helsinki , Eteläuomen Läi , United States , America , Edward Haeggstr , Astellas Pharma Europe , Christian Jones , Bluepharma Farmaceutica , Chris Halling , Astellas Pharma Inc , Prnewswire Nanoform Finland Plc , Danske Bank , Orientation Marketing Ltd , Finland Branch , Finland Plc , First Subject Visit , North America , Chief Executive Officer , Amorphous Solid Dispersions , Astellas Pharma , Chief Commercial , Orientation Marketing , Nasdaq First North Growth Market , Certified Adviser , Looking Statements , Financial Statements , Nanoform , Medical Pharmaceuticals , Health Care Amp Hospitals , Pharmaceuticals , Surveys , Olls And Research ,